In our previous study using a murine tumor model, anti-GM-CSF antibody significantly suppressed subcutaneous tumor growth of Lewis lung carcinoma (LLC), and a decreased density of TAMs and increased density of CTLs were observed in mice with anti-GM-CSF therapy [70]. This evidence concerns the gene CSF2 and Carcinoma, Lewis Lung.